🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the UK / NCT06905808
Recruiting Observational

e-Sense® Normal Values of Urodynamic Pressures Using e-Sense® Catheters

NCT06905808 · tracked via the Priya Life Science UK tracker
Sponsor
Laborie Medical Technologies Inc.
Phase
Observational
Started
2025-08-15
Last updated
2026-04-29

Condition(s) studied

Lower Urinary Track SymptomsUrodynamic Exam

Investigational drug(s) / intervention(s)

eSense 7Fr Single Sensor Bladder Catheter

eSense 7Fr Single Sensor Bladder Catheter: Urinary and abdominal catheters inserted into the body to measure pressure for urodynamics.

Study summary

In this post-market observational study, subjects referred to urodynamic testing will be approached to enroll in a clinical study to define the normal range of pressure values utilizing e-Sense® catheters. Urodynamic test results using the study devices will be provided back to the study sponsor for test interpretation and to publish. The urodynamic information collected using the study devices will be used in the UDS test interpretation for each subject enrolled, unless there is a reason to believe the test should be repeated (i.e. inconclusive results).

Eligibility

Sex
ALL
Min age
20 Years
Max age
Healthy volunteers
No
Inclusion Criteria: * Subjects medically indicated for Urodynamic procedure between ages 20-35 or \> 50 years old (equally split male and female) * Due to aging and giving birth significantly affecting the urethra: * Female subjects 20-35 should be nulliparous. * Female subjects \> 50 years old should have given birth to at least one child vaginally. Further caesarian births would not mean exclusion from the study. * Subjects with range of BMI values * Subject provides written authorization and/or consent per institution or geographical requirements Exclusion Criteria: * Subjects with cognitive or psychiatric conditions that interfere with or precludes direct and accurate communication regarding the study, giving informed consent * Any anal / rectal symptoms and/or surgery * Pregnant women * Subjects with active untreated bladder infections (not including patients with asymptomatic bacteruria) * Subjects having greater than 300 mL post void residual on the clinic visit uroflowmetry test

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Bristol Urological Institute Bristol United Kingdom Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06905808 on ClinicalTrials.gov ↗ ← All trials in the UK